Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Reckitt Benekiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, United Kingdom
Disprin.
| Pharmaceutical Form |
|---|
|
Dispersible tablet. |
| Active Ingredient | mg/Tablet | Specification |
|---|---|---|
| Aspirin | 300.00 | Ph Eur |
Excipient(s) with known effect:
Sodium 0.12 mg (0.005 mmol) per tablet,
Soy protein 0.0625–0.125 mg per tablet
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acetylsalicylic acid |
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
| List of Excipients |
|---|
|
Calcium carbonate |
Cardboard carton containing tablets in strips of aluminium foil with vinyl heat seal.
Pack sizes: 6, 8, 12, 16, 24, 32, 48, 96 and 500 tablets. (Those pack sizes printed in bold are currently sold).
Reckitt Benekiser Healthcare (UK) Limited, Dansom Lane, Hull, HU8 7DS, United Kingdom
PL 00063/0017
24/04/1995 / 23/02/2004
| Drug | Countries | |
|---|---|---|
| DISPRIN | Ireland, New Zealand, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
